Trial Profile
Facial nerve regeneration surgery using fibroblast growth factor in Bell's palsy and Hunt syndrome
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 01 Aug 2019
Price :
$35
*
At a glance
- Drugs Trafermin (Primary)
- Indications Bell palsy; Mucopolysaccharidosis II
- Focus Therapeutic Use
- 31 Jul 2019 Status changed from recruiting to discontinued.
- 30 Jan 2015 New trial record